The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical product shortages during disasters and opportunities to better predict, prevent and respond to shortages. The Department of Health and Human Services asked NASEM to convene the workshop in response to the shortage of intravenous saline solution exacerbated by the 2017 hurricane season. AHA, which participated on the workshop planning committee, last year called for a comprehensive strategy to address these and other critical drug shortages. In July, Food and Drug Administration Commissioner Scott Gottlieb, M.D., convened an interagency task force to report to Congress on the root causes of drug shortages and recommend new federal authorities to address them. FDA will hold a public meeting Nov. 27 to receive stakeholder input on the issue.

Related News Articles

Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…